Search Within

Shanu Modi

  1. "Cancer Research"
Formats
  1. Meeting Abstract (50)
Groups
  1. Breast Medicine Service (50)
  2. Department of Medicine (50)
  3. Solid Tumor Oncology Division (50)
  4. GSK Faculty (24)
  5. Survivorship Research (23)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (21)

More Groups

People
  1. Clifford Hudis (18)
  2. Sarat Chandarlapaty (13)
  3. Sujata Patil (13)
  4. Larry Norton (12)
  5. Diana Lake (11)
  6. Gabriella D'Andrea-Carlino (10)

More People

Years
  1. 2022 (2)
  2. 2021 (5)
  3. 2020 (4)
  4. 2019 (5)
  5. 2018 (3)
  6. 2017 (2)

More Years

Publications
  1. Cancer Research (50)
Publishers
  1. American Association for Cancer Research (50)

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I clinical trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer
    Meeting Abstract

    Jhaveri, K.; Cadoo, K.; Chandarlapaty, S.; Teplinsky, E.; Speyer, J.; D'Andrea, G.; Patil, S.; Haque, S.; Friedman, K.; Heese, S.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy
    Meeting Abstract

    Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • SGN-LIV1A: A phase 1 trial evaluating a novel antibody-drug conjugate in patients with LIV-1-positive breast cancer
    Meeting Abstract

    Forero, A.; Burris, H.; LoRusso, P.; Specht, J.; Miller, K.; Mita, M.; Liu, M. C.; Modi, S.; Pusztai, L.; Sussman, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Results from a phase 2a study of trastuzumab emtansine, paclitaxel, and pertuzumab in patients with HER2-positive metastatic breast cancer
    Meeting Abstract

    Elias, A.; Modi, S.; Krop, I. E.; Pegram, M.; Ipe, D.; Guardino, E. A.; Althaus, B.; LoRusso, P. L.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Morris, P. G.; Lake, D. E.; D'Andrea, G. M.; Dickler, M. N.; Gilewski, T. A.; Dang, C. T.; McArthur, H. L.; Bromberg, J. F.; Goldfarb, S. B.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
    Meeting Abstract

    Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A comprehensive study to analyze tumor sensitivity to HSP90 inhibition therapy
    Meeting Abstract

    Riolo, M.; Modi, S.; Corben, A.; Hudis, C.; Alpaugh, M.; Chiosis, G.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer
    Meeting Abstract

    Datko, F.; D'Andrea, G.; Dickler, M.; Theodoulou, M.; Goldfarb, S.; Lake, D.; Fornier, M.; Modi, S.; Sklarin, N.; Comen, E.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Beyond HER2 and hormonal agents: The heat shock protein 90 inhibitor ganetespib as a potential new breast cancer therapy
    Meeting Abstract

    Friedland, J. C.; Sang, J.; Modi, S.; Bradley, R.; Ei-Hariry, I.; Wada, Y.; Proia, D. A.
    Cancer Research (2011)

    Fulltext@MSK | Save